Trial Profile
A Long Term, Non-Comparative, Multi-Centre Study to Further Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Oct 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 30 Apr 2014 New trial record